Literature DB >> 17549438

Regulation of excitation by GABA(A) receptor internalization.

Nancy J Leidenheimer1.   

Abstract

Neuronal inhibition is of paramount importance in maintaining the delicate and dynamic balance between excitatory and inhibitory influences in the central nervous system. GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter in brain, exerts its fast inhibitory effects through ubiquitously expressed GABA(A) receptors. Activation of these heteropentameric receptors by GABA results in the gating of an integral chloride channel leading to membrane hyperpolarization and neuronal inhibition. To participate in neurotransmission, the receptor must reside on the cell surface. The trafficking of nascent receptors to the cell surface involves posttranslational modification and the interaction of the receptor with proteins that reside within the secretory pathway. The subsequent insertion of the receptor into specialized regions of the plasma membrane is dictated by receptor composition and other factors that guide insertion at synaptic or perisynaptic/extrasynaptic sites, where phasic and tonic inhibition are mediated, respectively. Once at the cell surface, the receptor is laterally mobile and subject to both constitutive and regulated endocytosis. Following endocytosis the receptor undergoes either recycling to the plasma membrane or degradation. These dynamic processes profoundly affect the strength of GABAergic signaling, neuronal inhibition, and presumably synaptic plasticity. Heritable channelopathies that affect receptor trafficking have been recently recognized and compelling evidence exists that mechanisms underlying acquired epilepsy involve GABA(A) receptor internalization. Additionally, GABA(A) receptor endocytosis has been identified as an early event in the ischemic response that leads to excitotoxicity and cell death. This chapter summarizes what is known regarding the regulation of receptor trafficking and cell surface expression and its impact on nervous system function from both cell biology and disease perspectives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17549438     DOI: 10.1007/400_2007_039

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  13 in total

1.  GABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptors.

Authors:  Randa S Eshaq; Letha D Stahl; Randolph Stone; Sheryl S Smith; Lucy C Robinson; Nancy J Leidenheimer
Journal:  Brain Res       Date:  2010-05-16       Impact factor: 3.252

2.  Agonist-dependent endocytosis of γ-aminobutyric acid type A (GABAA) receptors revealed by a γ2(R43Q) epilepsy mutation.

Authors:  Severine Chaumont; Caroline André; David Perrais; Eric Boué-Grabot; Antoine Taly; Maurice Garret
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

3.  Slow intracellular accumulation of GABA(A) receptor delta subunit is modulated by brain-derived neurotrophic factor.

Authors:  S Joshi; J Kapur
Journal:  Neuroscience       Date:  2009-08-07       Impact factor: 3.590

4.  Down-regulation of gephyrin and GABAA receptor subunits during epileptogenesis in the CA1 region of hippocampus.

Authors:  Marco I González; Yasmin Cruz Del Angel; Amy Brooks-Kayal
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

5.  GABAA receptor trafficking is regulated by protein kinase C(epsilon) and the N-ethylmaleimide-sensitive factor.

Authors:  Wen-Hai Chou; Dan Wang; Thomas McMahon; Zhan-Heng Qi; Maengseok Song; Chao Zhang; Kevan M Shokat; Robert O Messing
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

6.  Inhibitory role for GABA in autoimmune inflammation.

Authors:  Roopa Bhat; Robert Axtell; Ananya Mitra; Melissa Miranda; Christopher Lock; Richard W Tsien; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  Treatment with Mesenchymal-Derived Extracellular Vesicles Reduces Injury-Related Pathology in Pyramidal Neurons of Monkey Perilesional Ventral Premotor Cortex.

Authors:  Maria Medalla; Wayne Chang; Samantha M Calderazzo; Veronica Go; Alexandra Tsolias; Joseph W Goodliffe; Dhruba Pathak; Diego De Alba; Monica Pessina; Douglas L Rosene; Benjamin Buller; Tara L Moore
Journal:  J Neurosci       Date:  2020-04-02       Impact factor: 6.167

8.  Brain-derived neurotrophic factor promotes gephyrin protein expression and GABAA receptor clustering in immature cultured hippocampal cells.

Authors:  Marco I González
Journal:  Neurochem Int       Date:  2014-04-18       Impact factor: 3.921

Review 9.  Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy.

Authors:  Kerry Thompson
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

10.  GABA(A) Receptor Dynamics and Constructing GABAergic Synapses.

Authors:  Verena Tretter; Stephen J Moss
Journal:  Front Mol Neurosci       Date:  2008-05-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.